Efecte Oyj
EFECTE PLC -- COMPANY ANNOUNCEMENT -- 24 February 2021 at 9:45 am
Efecte Plc: Share subscriptions with options
A total of 28,500 shares of Efecte Plc have been subscribed for with 2011 stock options. The shares have been registered into the trade register on 24 February 2021, as of which date the new shares will carry equal shareholder rights with the company’s existing shares. Public trading begins on Nasdaq First North Growth marketplace operated by Nasdaq Helsinki Ltd as of 25 February 2021 together with the existing shares.
The entire subscription price of 16,530.00 euro will be recorded in the reserve of invested non-restricted equity, and the company’s share capital remains unchanged. The shares have no nominal value.
After the subscriptions, the number of Efecte’s shares will rise to 6,085,123 shares.
Additional information on the option programs are available on Efecte's website at www.efecte.com
Further inquiries:
Taru Mäkinen
CFO
Efecte Plc
taru.makinen@efecte.com
+358 40 507 1085
Certified Adviser:
Evli Bank Plc, tel +358 40 579 6210
Efecte Plc
Efecte helps service organizations digitalize and automate their work. Customers across Europe leverage our cloud service to operate with greater agility, to improve the experience of end-users, and to save costs. The use cases for our solutions range from IT service management and ticketing to improving employee experiences, business workflows, and customer service. We are the European Alternative to global players in our space. Our headquarters is located in Finland and we have regional hubs in Germany and Sweden. Efecte is listed on the Nasdaq First North Growth Market Finland marketplace.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.24.10.2025 13:30:44 CEST | Press release
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
The Government of Gangnan District, Guigang City24.10.2025 13:06:07 CEST | Press release
Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN
Ress Life Investments A/S24.10.2025 10:58:13 CEST | Press release
Ress Life Investments A/S, Decisions of the extraordinary general meeting held on 24 October 2025
Sveriges Riksbank24.10.2025 10:07:39 CEST | Press release
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
Marimekko Corporation24.10.2025 10:00:00 CEST | Press release
Release of Marimekko's Interim Report, 1 January–30 September 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
